
- Volume 0 0
ASPIRIN UNDER STUDY FOR ANTICANCER EFFECTS
Researchers are currently studying the possibleanticancer effects of aspirin. Aspirinblocks cyclooxygenase (COX), which helpsrestrict the blood supply to tumors, therebylimiting tumor growth. The studies of aspirininvolved exposing blood vessel cells to aspirinor COX-2 inhibitors like celecoxib. Aspirin athigh doses caused death of the blood vesselcells. This effect was not seen with standarddoses of aspirin or with COX-2 inhibitors.Investigators plan to continue studying theunderlying mechanism of aspirin's effect inorder to identify new targets for cancer drugs.
Dr. Garrett is a clinical pharmacistpractitioner at Cornerstone Health Carein High Point, NC.
Articles in this issue
about 19 years ago
Making Dry Eye Disappearabout 19 years ago
What You Need to Know About Cold Soresabout 19 years ago
Help for Chapped Lipsabout 19 years ago
can you READ these Rxs?about 19 years ago
compounding HOTLINEabout 19 years ago
A Review of Federal Legislation Affecting Pharmacy Practiceabout 19 years ago
Strategies and Tools for Promoting Medication Adherenceabout 19 years ago
The Role of the Pharmacist in Screening for CVD Riskabout 19 years ago
Drug Diversion in Vermontabout 19 years ago
Volunteerism Is the Heart of RESPy WinnerNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































